Abbott Divides To Strengthen Shareholder Value

BMI View: Abbott Laboratories' share price will outperform BMI's Pharma 20 Index over the next three months. The Illinois-based company will primarily benefit from the separation of its operations into diversified medical products and research-based pharmaceuticals. This dramatic shift in strategy will capitalise on the current investor affectation for having a clear focus on high-margin patented medicines.

To read the full article, please choose one of the following options: